Over the past 3 months, 11 analysts have published their opinion on Gilead Sciences (NASDAQ:GILD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding Read more

Gilead Sciences (GILD) Outpaces Stock Market Gains: What You Should Know

10:45pm, Friday, 03'rd Mar 2023 Zacks Investment Research

Gilead Sciences (GILD) closed the most recent trading day at $81.07, moving +1.82% from the previous trading session. Read more

Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?

11:20am, Monday, 27'th Feb 2023 Zacks Investment Research

Sector ETF report for PBE Read more

3 Stocks to Buy Right Now That Are Cash Cows

11:25am, Saturday, 25'th Feb 2023 The Motley Fool

If cash is king, these three stocks should wear crowns. Read more

WHO panel is reviewing whether COVID vaccines need to be updated

06:01pm, Friday, 24'th Feb 2023 MarketWatch

Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand. Read more

Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?

11:20am, Friday, 24'th Feb 2023 Zacks Investment Research

Smart Beta ETF report for SPHD Read more

Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?

11:20am, Thursday, 23'rd Feb 2023 Zacks Investment Research

Style Box ETF report for SPHD Read more

This Recession-Proof Company Has a Best-in-Class Dividend

12:30pm, Wednesday, 22'nd Feb 2023 The Motley Fool

Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group. Read more

How Are Biotech ETFs Reacting to Q4 Earnings Releases?

07:21pm, Tuesday, 21'st Feb 2023 Zacks Investment Research

The latest earnings from some of the big biotech players came in at mixed this reporting season. Read more

Is Global X SuperDividend U.S. ETF (DIV) a Strong ETF Right Now?

11:20am, Tuesday, 21'st Feb 2023 Zacks Investment Research

Smart Beta ETF report for DIV Read more

Gilead (GILD) Reports Positive Data From Urothelial Cancer Study

04:53pm, Monday, 20'th Feb 2023 Zacks Investment Research

Gilead's (GILD) new and updated positive results from a phase II study show Trodelvy's rapid and durable responses for patients across a range of hard-to-treat types of mUC. Read more

Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?

11:20am, Monday, 20'th Feb 2023 Zacks Investment Research

Style Box ETF report for SPYD Read more

The Zacks Analyst Blog Highlights Tesla, Eli Lilly, Bank of America, QUALCOMM and Gilead Sciences

04:39pm, Friday, 17'th Feb 2023 Zacks Investment Research

Tesla, Eli Lilly, Bank of America, QUALCOMM and Gilead Sciences are part of the Zacks top Analyst Blog. Read more

Top Analyst Reports for Tesla, Eli Lilly & Bank of America

04:00pm, Thursday, 16'th Feb 2023 Zacks Investment Research

Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Eli Lilly and Company (LLY) and Bank of America Corporation (BAC). Read more

5 Least-Hurt Biotech ETFs of the Last Week

06:00pm, Wednesday, 15'th Feb 2023 Zacks Investment Research

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days. Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by